KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Vir Biotechnology (VIR) Non Operating Income (2018 - 2025)

Vir Biotechnology (VIR) has disclosed Non Operating Income for 8 consecutive years, with -$335000.0 as the latest value for Q4 2025.

  • Quarterly Non Operating Income fell 100.51% to -$335000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $36.4 million through Dec 2025, down 56.04% year-over-year, with the annual reading at -$409000.0 for FY2025, 100.64% down from the prior year.
  • Non Operating Income hit -$335000.0 in Q4 2025 for Vir Biotechnology, down from $10.5 million in the prior quarter.
  • In the past five years, Non Operating Income ranged from a high of $164.1 million in Q3 2021 to a low of -$91.9 million in Q1 2022.
  • Historically, Non Operating Income has averaged $13.6 million across 5 years, with a median of $865500.0 in 2021.
  • Biggest five-year swings in Non Operating Income: plummeted 1049.1% in 2021 and later soared 6580.14% in 2025.
  • Year by year, Non Operating Income stood at -$25.9 million in 2021, then skyrocketed by 416.71% to $81.9 million in 2022, then plummeted by 77.71% to $18.3 million in 2023, then soared by 260.23% to $65.8 million in 2024, then tumbled by 100.51% to -$335000.0 in 2025.
  • Business Quant data shows Non Operating Income for VIR at -$335000.0 in Q4 2025, $10.5 million in Q3 2025, and $7.6 million in Q2 2025.